A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients
- R. J.M. Brüggemann
- , W. J.F.M. Van Der Velden
- , C. A.J. Knibbe
- , A. Colbers
- , S. Hol
- , D. M. Burger
- , J. P. Donnelly
- , N. M.A. Blijlevens
Research output: Contribution to journal › Article › peer-review
29
Citations
(Scopus)